EDEN PRAIRIE, Minn., July 24, 2024 /PRNewswire/ -- inFormed Consent, a pioneer in digital informed consent and patient education technology,…
Announcing Sustainability Benchmarking Initiative and New Gen-AI Features of Pharma.AI Platform CAMBRIDGE, Mass., July 24, 2024 /PRNewswire/ -- Insilico Medicine…
NEW YORK, July 24, 2024 /PRNewswire/ -- Datavant, the leading health data platform company, announced today its upcoming participation in…
New capability provides sponsors and CROs holistic view of sites' patient recruitment progress COLUMBIA, Md., July 24, 2024 /PRNewswire/ -- Advarra, the…
Trial is first of its kind to measure EF severity direct-from-ECG NEW YORK, July 24, 2024 /PRNewswire/ -- Peerbridge Health…
SHELTON, CT / ACCESSWIRE / July 24, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader…
OCALA, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the…
Reduction of key proteins in the interleukin 4 (IL-4) and IL-13 signalling pathway via SHP-1 activation is a key component…
Dallas, Texas, July 24, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a leader in men’s…
TEL AVIV, Israel, July 24, 2024 (GLOBE NEWSWIRE) -- ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular…